BMO Capital lowered the firm’s price target on Masco (MAS) to $65 from $75 and keeps a Market Perform rating on the shares. The stock is likely to remain range bound in the near-term due to uncertainty around tariffs, the analyst tells investors in a research note. While the balance sheet is healthy, price hikes to mitigate the tariff drag puts further downward pressure on demand, and the case to buy the stock today isn’t obvious against the backdrop of weakening demand and tariffs, the firm says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MAS: